Moderna Inc (MRNA)
Interest coverage
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | -4,239,000 | 9,420,000 | 13,296,000 | -763,000 | -546,000 |
Interest expense | US$ in thousands | 38,000 | 29,000 | 17,000 | 9,891 | 6,557 |
Interest coverage | -111.55 | 324.83 | 782.12 | -77.14 | -83.27 |
December 31, 2023 calculation
Interest coverage = EBIT ÷ Interest expense
= $-4,239,000K ÷ $38,000K
= -111.55
The interest coverage ratio for Moderna Inc is not provided in the data table for the years ending December 31, 2019 to 2023. The interest coverage ratio is a measure of a company's ability to meet its interest obligations on its debt. It is calculated by dividing the earnings before interest and taxes (EBIT) by the interest expense. A higher interest coverage ratio indicates that the company is more capable of servicing its debt obligations. Without this ratio data, a detailed analysis of Moderna Inc's ability to cover its interest payments cannot be performed.
Peer comparison
Dec 31, 2023
Company name
Symbol
Interest coverage
Moderna Inc
MRNA
-111.55
Amgen Inc
AMGN
2.75
Bio-Techne Corp
TECH
13.13
Biogen Inc
BIIB
6.25
Gilead Sciences Inc
GILD
8.32
Halozyme Therapeutics Inc
HALO
19.57
Krystal Biotech Inc
KRYS
—
Neurocrine Biosciences Inc
NBIX
73.20
Regenxbio Inc
RGNX
-37.42
Repligen Corporation
RGEN
33.87
Vericel Corp Ord
VCEL
-2.95